BMC Medical Future Growth
Future criteria checks 5/6
BMC Medical is forecast to grow earnings and revenue by 40.4% and 25.8% per annum respectively. EPS is expected to grow by 35.1% per annum. Return on equity is forecast to be 10.6% in 3 years.
Key information
40.4%
Earnings growth rate
35.1%
EPS growth rate
| Medical Equipment earnings growth | 23.6% |
| Revenue growth rate | 25.8% |
| Future return on equity | 10.6% |
| Analyst coverage | Low |
| Last updated | 29 Sep 2024 |
Recent future growth updates
Recent updates
Some BMC Medical Co., Ltd. (SZSE:301367) Analysts Just Made A Major Cut To Next Year's Estimates
Sep 10
Capital Allocation Trends At BMC Medical (SZSE:301367) Aren't Ideal
Aug 21BMC Medical's (SZSE:301367) Dividend Will Be Reduced To CN¥1.00
May 24The Consensus EPS Estimates For BMC Medical Co., Ltd. (SZSE:301367) Just Fell Dramatically
May 10Why BMC Medical's (SZSE:301367) Shaky Earnings Are Just The Beginning Of Its Problems
Apr 19Market Cool On BMC Medical Co., Ltd.'s (SZSE:301367) Earnings Pushing Shares 27% Lower
Apr 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,438 | 376 | N/A | 327 | 2 |
| 12/31/2025 | 1,407 | 370 | N/A | 393 | 3 |
| 12/31/2024 | 993 | 224 | N/A | 304 | 2 |
| 6/30/2024 | 758 | 146 | 122 | 141 | N/A |
| 3/31/2024 | 834 | 192 | 129 | 151 | N/A |
| 12/31/2023 | 1,122 | 297 | 127 | 151 | N/A |
| 9/30/2023 | 1,346 | 381 | 250 | 276 | N/A |
| 6/30/2023 | 1,599 | 471 | 292 | 321 | N/A |
| 3/31/2023 | 1,689 | 483 | 383 | 410 | N/A |
| 1/1/2023 | 1,415 | 380 | 351 | 375 | N/A |
| 9/30/2022 | 1,223 | 297 | 241 | 259 | N/A |
| 1/1/2022 | 663 | 146 | 94 | 104 | N/A |
| 12/31/2020 | 560 | 228 | 252 | 267 | N/A |
| 12/31/2019 | 258 | 39 | 31 | 36 | N/A |
| 12/31/2018 | 189 | 25 | 18 | 21 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 301367's forecast earnings growth (40.4% per year) is above the savings rate (2.9%).
Earnings vs Market: 301367's earnings (40.4% per year) are forecast to grow faster than the CN market (23.3% per year).
High Growth Earnings: 301367's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 301367's revenue (25.8% per year) is forecast to grow faster than the CN market (13.2% per year).
High Growth Revenue: 301367's revenue (25.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 301367's Return on Equity is forecast to be low in 3 years time (10.6%).